Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy

Triple negative breast cancer (TNBC) is a heterogeneous disease associated with poor clinical outcome and lack of targeted therapy. Here we show that prolactin (PRL) and its signaling pathway serve as a sub-classifier and predictor of pro-differentiation therapy in TNBC. Using immunohistochemistry a...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Ozuna, Vanessa M., Hachim, Ibrahim Y., Hachim, Mahmood Y., Lebrun, Jean-Jacques, Ali, Suhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969612/
https://www.ncbi.nlm.nih.gov/pubmed/27480353
http://dx.doi.org/10.1038/srep30934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969612/
https://www.ncbi.nlm.nih.gov/pubmed/27480353
http://dx.doi.org/10.1038/srep30934

Ejemplares similares